5/18/2026Harbour BioMed Unveils Promising Preclinical Data for AI-Designed Obes...

5/18/2026AbbVie's Epcoritamab Wins First China Approval for Relapsed or Refract...

5/18/2026China Approves Salubris' Once-Weekly Teriparatide for Osteoporosis

5/18/2026Haisco Pharma to Present Positive Phase III PNH Data for Factor B Inhi...

5/15/2026Recent Executive Moves

5/15/2026Kovyi Pharma Raises Pre-A Round for Neuropathic Pain Programs

5/15/2026Yirui Pharma Raises CNY 100Ms A++ Round to Advance Autoimmune Pipeline

5/15/2026CDE Issues New TCM Post-Approval Change Review Guidelines

5/15/2026CDE Issues Revised Review Guideline for Biologics Change Applications

5/15/2026CDE Releases Revised Review Guideline for Chemical Drug Change Applica...

5/15/2026CDE Releases Operational Procedures for Drug Trial Data Protection Sys...

More>>

5/18/2026China's RWE Evolution: From Pilot to Practice (Simon-Kucher)

5/18/2026Nature Analysis Highlights China's Rise as Global Clinical Trial Hub

5/14/2026Pharma CEOs Missing From Trump's China Delegation

5/14/2026Life Sciences a "Sweet Spot" for U.S.-China Cooperation Ahead of Trump...

5/11/2026China Emerges as Global Hub for siRNA Out-Licensing Deals: PharmaDJ

5/5/2026A Strategic Playbook for Chinese Biotech Cross-Border Deals: Navigatin...

5/1/2026A Biopharmaceutical Superpower: China's Rise, Its Limits, and What Com...

4/29/2026China Partnerships Drive Biopharma Deal Surge to $79B in Q1 2026

4/29/2026From fast follower to originator: How Asia is rewiring biopharma innov...

4/28/2026China Imposes Four-Year Deadline on Conditionally Approved Drugs, Tigh...

4/27/2026China Biopharma Financing Rebounds in March as AI Startups and Mega-De...

More>>